IMMX
Immix Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.50
−1.73%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+31.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| May 29, 2026 | Adams Helen C. · director | A-Award | 6,250 | $0.00 |
| May 29, 2026 | BUCHAN JANE · director | A-Award | 12,500 | $8.78 |
| May 29, 2026 | BUCHAN JANE · director | A-Award | 6,250 | $0.00 |
| May 29, 2026 | Hsu Jason · director | A-Award | 12,500 | $8.78 |
| May 29, 2026 | Hsu Jason · director | A-Award | 6,250 | $0.00 |
| May 29, 2026 | Chudnovsky Yekaterina · director | A-Award | 12,500 | $8.78 |
| May 29, 2026 | Chudnovsky Yekaterina · director | A-Award | 6,250 | $0.00 |
| May 29, 2026 | Rachman Ilya M · director, officer: CEO and Chairman | A-Award | 500,000 | $8.78 |
| May 29, 2026 | CHANG NANCY T · director | A-Award | 12,500 | $8.78 |
| May 29, 2026 | CHANG NANCY T · director | A-Award | 6,250 | $0.00 |
| May 29, 2026 | Morris Gabriel S · director, officer: CFO, President | A-Award | 500,000 | $8.78 |
| May 29, 2026 | Marquet Magda · director | A-Award | 12,500 | $8.78 |
| May 29, 2026 | Marquet Magda · director | A-Award | 6,250 | $0.00 |
| May 29, 2026 | Ng Carey · director | A-Award | 12,500 | $8.78 |
| May 29, 2026 | Ng Carey · director | A-Award | 6,250 | $0.00 |
| May 29, 2026 | Adams Helen C. · director | A-Award | 12,500 | $8.78 |
| Dec 11, 2025 | CHANG NANCY T · director | A-Award | 39,643 | $4.33 |
| Dec 10, 2025 | Rachman Ilya M · director, officer: CEO and Chairman | Purchase | 746 | $6.67 |
| Dec 10, 2025 | Morris Gabriel S · director, officer: CFO | Purchase | 770 | $6.58 |
| Sep 17, 2025 | Morris Gabriel S · director, officer: CFO | Purchase | 2,600 | $1.97 |
| Sep 17, 2025 | Rachman Ilya M · director, officer: CEO and Chairman | Purchase | 2,500 | $2.02 |
| Jun 23, 2025 | BUCHAN JANE · director | A-Award | 33,000 | $2.24 |
| Jun 23, 2025 | Chudnovsky Yekaterina · director, 10 percent owner: | A-Award | 33,000 | $2.24 |
| Jun 23, 2025 | Ng Carey · director | A-Award | 33,000 | $2.24 |
| Jun 23, 2025 | Morris Gabriel S · director, officer: CFO | A-Award | 340,000 | $2.24 |
| Jun 23, 2025 | Marquet Magda · director | A-Award | 33,000 | $2.24 |
| Jun 23, 2025 | Hsu Jason · director | A-Award | 33,000 | $2.24 |
| Jun 23, 2025 | Adams Helen C. · director | A-Award | 33,000 | $2.24 |
| Jun 23, 2025 | Rachman Ilya M · director, officer: CEO and Chairman | A-Award | 340,000 | $2.24 |
| Jun 20, 2025 | Morris Gabriel S · director, officer: CFO | Purchase | 2,225 | $2.28 |
Institutional positioning
13F filings over the trailing two quarters
New 70Increased 62Reduced 27Sold out 11
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Jupiter Topco LLC | New Position | 9,783,192 | Aug 14, 2026 |
| JANUS HENDERSON GROUP PLC | Increased | 4,802,002 | May 18, 2026 |
| Saturn V Capital Management LP | Increased | 4,658,429 | Aug 14, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | Increased | 3,891,019 | Aug 14, 2026 |
| SATURN V CAPITAL MANAGEMENT LLC | Increased | 3,693,585 | May 15, 2026 |
| STATE STREET CORP | Increased | 2,996,935 | Aug 7, 2026 |
| BlackRock, Inc. | Increased | 2,989,972 | Aug 7, 2026 |
| Deep Track Capital, LP | New Position | 2,775,000 | Aug 14, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | Unchanged | 2,549,019 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 2,507,122 | Aug 13, 2026 |
| Opaleye Management Inc. | New Position | 2,345,000 | Aug 14, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 2,066,426 | Aug 14, 2026 |
| UBS Group AG | Increased | 1,941,817 | Aug 13, 2026 |
| MARSHALL WACE, LLP | Increased | 1,794,908 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,787,994 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing May 29, 2026